NPM1 and acute myeloid leukemia: Furthermore a survival advantage for patients with CEBPA promoter hypermethylation was seen within a subcohort of 25 CN-AML patients with wt CEBPA and wt NPM1. However, these results were based on a relatively small number of cases analyzed.